http://www.tathasta.com/2021/01/cdc-study-59-of-new-covid-19-infections.html
- January 11, 2021
Nearly six in 10 new COVID-19 infections are spread by people who show no symptoms of the virus, according to a new study.
The Centers for Disease Control and Prevention (CDC) study found that asymptomatic people made up about 24% of all transmissions. Meanwhile, pre-symptomatic individuals, those who have contracted the virus but do not yet have symptoms, accounted for 35% of new cases.“In the absence of effective and widespread use of therapeutics or vaccines that can shorten or eliminate infectivity, successful control of SARS-CoV-2 cannot rely solely on identifying and isolating symptomatic cases; even if implemented effectively, this strategy would be insufficient,” the CDC researchers wrote in their study. “These findings suggest that effective control also requires reducing the risk of transmission from people with infection who do not have symptoms.”
Jay Butler, CDC deputy director for infectious diseases and a lead author of the study, said the study findings support public health guidelines that call for masks and social distancing.
“There was still some controversy over the value of community mitigation — face masks, social distancing, and hand hygiene — to limit spread,” Dr. Butler told Business Insider. “This study demonstrates that while symptom screening may have some value, mitigation, as well as strategically planned testing of persons in some setting, will be a significant benefit.”
Said the study: “The baseline assumptions for the model were that peak infectiousness occurred at the median of symptom onset and that 30% of individuals with infection never develop symptoms and are 75% as infectious as those who do develop symptoms. Combined, these baseline assumptions imply that persons with infection who never develop symptoms may account for approximately 24% of all transmission. In this base case, 59% of all transmission came from asymptomatic transmission, comprising 35% from presymptomatic individuals and 24% from individuals who never develop symptoms. Under a broad range of values for each of these assumptions, at least 50% of new SARS-CoV-2 infections was estimated to have originated from exposure to individuals with infection but without symptoms.”
The study concludes: “In this decision analytical model of multiple scenarios of proportions of asymptomatic individuals with COVID-19 and infectious periods, transmission from asymptomatic individuals was estimated to account for more than half of all transmissions. In addition to identification and isolation of persons with symptomatic COVID-19, effective control of spread will require reducing the risk of transmission from people with infection who do not have symptoms. These findings suggest that measures such as wearing masks, hand hygiene, social distancing, and strategic testing of people who are not ill will be foundational to slowing the spread of COVID-19 until safe and effective vaccines are available and widely used.”
But the CDC said “this study has limitations.”
“First, we used a simplistic model to represent a complex phenomenon, ie, the average infectiousness of SARS-CoV-2 infections over time. We used this model deliberately to test assumptions about the timing of peak infectiousness and transmission among asymptomatic individuals so that we could vary only these 2 critical parameters and assess their relative effects. Therefore, these results lack quantitative precision, but they demonstrate the qualitative roles of these 2 components and show that across broad ranges of possible assumptions, the finding that asymptomatic transmission is a critical component of SARS-CoV-2 transmission dynamics remains constant.”
Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19Category: COVID-19 Treatments
- Fielden Nolan (nolanf), 01/17/2021
|
![]() |
Current CDC Infection Mortality Rate RatiosCOVID-19 Pandemic Planning ScenariosCategory: Related CDC Documents
- Fielden Nolan (nolanf), 12/26/2020
|
![]() |
EXPERIMENTS TO DETERMINE MODE OF SPREAD OF INFLUENZACategory: Published Studies: Masks are INEFFECTIVE
- Fielden Nolan (nolanf), 12/17/2020
|
![]() |
Ivermectin is effective for COVID-19: meta analysis of 24 studiesEarly treatment is most successful, with an estimated reduction of 87%Category: Treatment
- Fielden Nolan (nolanf), 12/13/2020
|
![]() |
From: https://www.americasfrontlinedoctors.com/wp-content/uploads/2020/09/Masks-Science.pdf Masks do not prevent virus respiratory illness. Size matters! Viruses are 50x smaller than bacteria and 1000x smaller than a hair ... READ MORE
- Fielden Nolan (nolanf), 12/11/2020
|
![]() |
Face Mask Exempt CareFreedom to Breathe: Wearing a mask or any other "face covering" is NOT a lawCategory: Downloadables
- Fielden Nolan (nolanf), 12/09/2020
|
![]() |
CBER Plans for Monitoring COVID-19 Vaccine Safety and EffectivenessDocument is in the .PDF format... READ MORE
- Fielden Nolan (nolanf), 12/09/2020
|
![]() |
- December 7, 2020See attached .pdf document link.Evidence on the protective effect of mask use in community settings At present there is only limited and inconsistent scientific evidence to support the effectiveness of masking of healthy people in the community to prevent infection with respiratory viruses, including SARS-CoV-2 (75). A large randomized community-based tr... READ MORE
- Fielden Nolan (nolanf), 12/07/2020
|
![]() |
Ecacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 PandemicCategory: Treatment
- Fielden Nolan (nolanf), 11/27/2020
|
![]() |
COVID-19 Alternative StrategyA Case for Health and Socioeconomic WellbeingCategory: Published Studies: Masks are INEFFECTIVE
- Fielden Nolan (nolanf), 11/19/2020
|